NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EnsoData

EnsoData

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.ensodata.com/

Last Round

Debt

May 12, 2026

Total Funding Raised

$51.06M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EnsoData is a healthcare technology company that provides an AI-powered software platform to automate the analysis of sleep studies for clinicians.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

sleep medicinepolysomnographyPSGhome sleep apnea testingHSATmedical AIsleep diagnosticsSaMDsoftware as a medical deviceclinical workflow automationsleep study scoringAI sleep analysisdigital healthhealthcare SaaSpulse oximetrymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnsoData Comps

Public and private peers based on sector, stage, and business model.

EnsoData comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EnsoData Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 12, 2026
Series BJun 25, 2025
Series A ExtensionJun 3, 2022
Series AJun 10, 2020
SeedMar 2, 2018
Seed
Apr 13, 2016

Key People

Founding team and executive leadership

Nick Glattard

Co-founder CTO

Founding Team

Justin Mortara

President & CEO Investor

Executive Team

Matt Dobereiner

Chief Financial Officer

Executive Team

EnsoData Investors

Notable investors and investment history

EnsoData investors
InvestorRounds
M25Series A Extension, Series B, Seed
HealthX VenturesSeries A Extension, Series A, Seed
Colle CapitalSeries A Extension, Series A, Seed
Dreamit VenturesSeries A
Zetta Venture PartnersSeries A Extension, Series B, Series A
Questa CapitalSeries B
CIBC Innovation BankingDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    EnsoHST product cleared for AI-powered sleep diagnosis.

  • Mar 1, 2026

    EnsoSleep product receives FDA clearance for scoring and study management.

EnsoData Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnsoData Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnsoData's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range80
Year Founded2015
Last FundingMay 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.